FierceBiotech Jan 27, 2026 Rethinking heart attacks as nervous system gone haywire sparks potential new drug targets
FierceBiotech Jan 27, 2026 TD Cowen picks top 3 medtech prospects across its ‘Bones, Bots, and No More Shots’ portfolio
FierceBiotech Jan 27, 2026 'AI-native' outpatient surgery startup Oath Surgical inks Nvidia partnership
FierceBiotech Jan 27, 2026 United Therapeutics' bioengineered temporary liver shows promise in phase 1 trial
FierceBiotech Jan 27, 2026 From gene therapies to … firearms? Italian biotech makes unexpected strategic pivot
FierceBiotech Jan 27, 2026 Lisata reclaims China rights to solid tumor candidate ahead of acquisition
FierceBiotech Jan 27, 2026 After patient death, FDA lifts hold on 1 of 2 late-stage trials testing Intellia’s CRISPR therapy